-
have developed a range of genetic engineering strategies to modify EVs for the purpose of drug delivery. In addition to EVs, the EL Andaloussi lab also engineers various conjugates for extrahepatic
-
. However, progress is constrained by the scarcity of high-quality, well-characterized in vitro T-cell immunogenicity data. In this project, we will leverage expertise and technology in peptide T-cell
-
experience and enhanced potential to receive an ERC Starting Grant in the future. Open to both PhD (natural sciences) and MD (medical sciences) holders. From a variety of academic backgrounds: molecular
-
, measuring, basic brain science, etc.), Medical Science (brain medical science, immunology, oncology, genome science, etc.) and Engineering that relate to research being conducted at RIKEN. Qualifications